Trial Outcomes & Findings for Fentanyl Test in Children's Adenotonsillectomy (NCT NCT02484222)

NCT ID: NCT02484222

Last Updated: 2019-07-09

Results Overview

Recruitment status

COMPLETED

Target enrollment

80 participants

Primary outcome timeframe

average 1 hour from extubation

Results posted on

2019-07-09

Participant Flow

Children at age of 3 - 7 years with OSAS,The exclusion criteria were craniofacial deformities, mental retardation, BMI \> 22 kg/m², a history of bronchial asthma, and a recent history of opioid use.

Participant milestones

Participant milestones
Measure
The Result of Fentanyl Test
The children were divided by the breath decreasing rates-with 50% decreasing rate of breath were positive result, and the rest were negative.
Overall Study
STARTED
80
Overall Study
COMPLETED
77
Overall Study
NOT COMPLETED
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Fentanyl Test in Children's Adenotonsillectomy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
The Result of Fentanyl Test
n=80 Participants
The children were divided by the breath decreasing rates-with 50% decreasing rate of breath were positive result, and the rest were negative.
Age, Categorical
<=18 years
80 Participants
n=99 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=99 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
Age, Continuous
5.2 years
n=99 Participants
Sex: Female, Male
Female
65 Participants
n=99 Participants
Sex: Female, Male
Male
15 Participants
n=99 Participants
Region of Enrollment
China
80 Participants
n=99 Participants

PRIMARY outcome

Timeframe: average 1 hour from extubation

Outcome measures

Outcome measures
Measure
The Result of Fentanyl Test
n=77 Participants
The children were divided by the breath decreasing rates-with 50% decreasing rate of breath were positive result, and the rest were negative.
Rescue Morphine Requirement
30 mg
Interval 20.0 to 40.0

SECONDARY outcome

Timeframe: average 1 hour from extubation

Outcome measures

Outcome measures
Measure
The Result of Fentanyl Test
n=77 Participants
The children were divided by the breath decreasing rates-with 50% decreasing rate of breath were positive result, and the rest were negative.
Post-operative Nausea and Vomiting
13 Participants

SECONDARY outcome

Timeframe: average 1 hour from extubation

Outcome measures

Outcome measures
Measure
The Result of Fentanyl Test
n=77 Participants
The children were divided by the breath decreasing rates-with 50% decreasing rate of breath were positive result, and the rest were negative.
Number of Participants With Pulse Oxygen Saturation Less Than 95 Percent
7 Participants

POST_HOC outcome

Timeframe: average 1 hour from extubation

The number of participants who were light consumers of morphine as identified by the Fentanyl Test,we want to know the accurate of the test.The light consumers are the children of who used total morphine \<50 μg/kg.

Outcome measures

Outcome measures
Measure
The Result of Fentanyl Test
n=77 Participants
The children were divided by the breath decreasing rates-with 50% decreasing rate of breath were positive result, and the rest were negative.
Number of Participants Who Were Light Consumers of Morphine as Identified by the Fentanyl Test
47 Participants

Adverse Events

The Result of Fentanyl Test

Serious events: 0 serious events
Other events: 13 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
The Result of Fentanyl Test
n=77 participants at risk
The children were divided by the breath decreasing rates-with 50% decreasing rate of breath were positive result, and the rest were negative.
General disorders
vomiting
16.9%
13/77 • Number of events 13 • 1 hour
Post-operative Nausea/vomiting (PONV) and other adverse events, such as airway obstruction, laryngospasm.

Additional Information

Dr.Wang Xuan

the Children's Hospital of Fudan University

Phone: 18017591058

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place